补体系统遗传变异在年龄相关性黄斑变性中的意义
本文综述补体系统遗传变异与年龄相关性黄斑变性(AMD)的关联,指出遗传关联及局部眼组织和全身循环中补体激活升高证实了补体系统与AMD的强联系。多种补体抑制剂在临床试验中探索但迄今成功有限,多数AMD患者仍无治疗选择。文章概述了研究补体激活分子过程的各种实验方法及其发现、优势与挑战,并展望患者来源诱导多能干细胞和基因组编辑技术如何填补知识空白并助力有效补体靶向治疗策略的开发。
要点
- 补体系统是AMD的主要致病通路之一,遗传关联和补体激活升高支持其关键作用。
- 多种补体抑制剂临床试验迄今成功有限,多数AMD患者仍缺乏治疗选择。
- 患者来源诱导多能干细胞和基因组编辑技术为研究AMD机制和测试新疗法提供新机会。
核心结论
- 补体系统与AMD存在强关联,但补体靶向治疗临床试验成功有限,仍需填补功能意义和临床转化间的知识空白。
研究设计与样本
- 本文为综述,广泛概述了用于理解AMD发病中补体激活分子过程的实验方法,讨论各方法的发现、优势与挑战。
主要发现
- 遗传关联及AMD患者局部眼组织和全身循环中补体激活升高证实了补体系统与AMD的强联系。
- 多种补体抑制剂已在或正在临床试验中探索,但迄今成功有限,多数AMD患者仍无治疗选择。
临床怎么用
- 补体系统是AMD的重要致病通路,但当前补体抑制剂临床获益有限,需进一步研究以指导治疗策略。
局限性
- 补体系统在AMD发病中的功能意义及如何实现临床转化仍存在知识空白。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Age-related macular degeneration (AMD) is the main cause of vision loss among the elderly in the Western world. While AMD is a multifactorial disease, the complement system was identified as one of the main pathways contributing to disease risk. The strong link between the complement system and AMD was demonstrated by genetic associations, and by elevated complement activation in local eye tissue and in the systemic circulation of AMD patients. Several complement inhibitors have been and are being explored in clinical trials, but thus far with limited success, leaving the majority of AMD patients without treatment options to date. This indicates that there is still a gap of knowledge regarding the functional implications of the complement system in AMD pathogenesis and how to bring these towards clinical translation. Many different experimental set-ups and disease models have been used to study complement activation in vivo and in vitro, and recently emerging patient-derived induced pluripotent stem cells and genome-editing techniques open new opportunities to study AMD disease mechanisms and test new therapeutic strategies in the future. In this review we provide an extensive overview of methods employed to understand the molecular processes of complement activation in AMD pathogenesis. We discuss the findings, advantages and challenges of each approach and conclude with an outlook on how recent, exciting developments can fill in current knowledge gaps and can aid in the development of effective complement-targeting therapeutic strategies in AMD.
引用
- de Jong S, Gagliardi G, Garanto A, et al. Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res. 2021. PMID: 33610747. doi:10.1016/j.preteyeres.2021.100952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。